GE HealthCare Stock Drops 22.7% Amid Slow Growth and Margin Concerns

Yahoo Finance··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

GE HealthCare shares have fallen 22.7% since January 2026 to $64.05, driven by soft quarterly results. The company’s revenue grew at a compounded annual rate of just 4.4% over the past four years, below sector expectations. Organic revenue growth averaged only 3% annually over the last two years, signaling weak demand in its core imaging and diagnostics business. Free cash flow margin remained flat at 7.2% over the trailing twelve months, showing no improvement in five years. The stock now trades at 13.1 times forward earnings, but analysts see better opportunities elsewhere.

Impact on assets 5

Artificial Intelligence▲ · 2 stocks
Biotech & Genomic Medicine▼ · 1 stocks
GE HealthCare Technologies Inc.
GEHC
▼ NegativeDemandCapitalrelevance

Organic revenue growth averaged only 3% annually, signaling weak demand in core imaging and diagnostics business.

Cybersecurity & Digital Trust▲ · 1 stocks
Spatial Computing / AR/VR▲ · 1 stocks
© 2026 MarketIVNews